Atlas Trials

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Clinical trial NCT00263627 · COMPLETED

Trial details

NCT number
NCT00263627
Sponsor
Allergopharma GmbH & Co. KG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pollen Allergy
Start date
2005-06-01
Primary completion
2007-06-01
Enrollment
253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.